Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2019-10-15 | 2019-10-15 |
| Drug Identification Number | 02017741 | 02017741 |
| Brand name | RESONIUM CALCIUM | RESONIUM CALCIUM |
| Common or Proper name | Resonium Calcium | Resonium Calcium |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | CALCIUM POLYSTYRENE SULFONATE | CALCIUM POLYSTYRENE SULFONATE |
| Strength(s) | 999MG | 999MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | ORAL RECTAL | ORAL RECTAL |
| Packaging size | 1 | 1 |
| ATC code | V03AE | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2019-06-07 | 2019-06-07 |
| Actual start date | ||
| Estimated end date | 2019-09-30 | 2019-09-30 |
| Actual end date | 2019-08-13 | 2019-08-13 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | The anticipated availability dates represent estimated availabilities at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. | The anticipated availability dates represent estimated availabilities at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments |